Trade Ideas

Actionable trade ideas with entry/stop/target and risk framing.

Search Articles
ANTERO RESOURCES CORPORATION
Jan 13, 2026

Buy the Natural Gas Megatrend: Antero (AR) Trade Setup Backed by Reserves and Cash Flow

Entry, stop and targets for a commodity-exposed E&P with strong cash generation and a liquids tilt

Antero Resources (AR) is a high-conviction, tactical long on a dip. The company sits on 17.9 Tcf equivalent of proven reserves, produced ~3,424 MMcfe/...

Trade Idea Long
GSI Technology
Jan 13, 2026

GSI Technology: Small SRAM Specialist, Big Optionality — Speculative Buy on Improving Cash Flow

Revenue growth and margin leverage are showing up; buy for a tactical position with tight risk control as the company scales toward profitability.

GSI Technology (GSIT) is a micro-cap memory and APU specialist showing sequential revenue growth, improving operating cash flow and a clean balance sh...

Trade Idea Long
Boeing Company
Jan 13, 2026

Boeing's 737 MAX Momentum — A Tactical Long with Defined Risk

Production and orders are finally translating into cashflow; buy the near-term momentum with a disciplined stop.

Boeing's stock is rallying as 737 MAX deliveries, fresh orders and defense wins tighten the revenue outlook. Balance-sheet headaches remain, but recen...

Trade Idea Long
The Timken Company
Jan 13, 2026

Timken: A Stability Trade, Not a Growth Story

High-quality cash flow and a growing dividend make TKR a defensive holding — but the valuation already prices the calm, not the upside

Timken (TKR) is trading like a mature industrial: steady revenues, solid operating cash flow, and a consistent dividend hike cadence. That stability i...

Trade Idea Short
Duolingo, Inc. Class A Common Stock
Jan 13, 2026

Duolingo: Uncertainty Priced In — Buy the Optionality on a New Growth Engine

Q3 2025 tax benefit distorted earnings, but revenue momentum, strong cash flow and underappreciated AI/DET/maths monetization make a tactical long worth a swing-sized bet.

Duolingo stock has been punished for near-term execution noise and headline risk; the balance sheet, recurring revenue growth and nascent product mone...

Trade Idea Long
Jan 13, 2026

ZIM: Buy Calls Against a Low-Volatility Takeover Tail – Tactical Swing Idea

Strategic-review headlines create asymmetric upside; use limited-risk call exposure rather than stock until deal clarity arrives.

ZIM has been in the boardroom headlines for months, but the share-price reaction has been surprisingly muted. With the stock trading $21.57 on 01/13/2...

Trade Idea Long
Affirm Holdings, Inc. Class A Common Stock
Jan 13, 2026

Buy Affirm on a Regulatory Tailwind - Credit-Card APR Cap Could Reprice BNPL

Affirm looks positioned to benefit if lawmakers cap credit-card interest rates; trade the name with a defined entry, stop and two-tier target plan.

Affirm (AFRM) is a leader in buy-now, pay-later with ~ $36B in transaction volume in fiscal 2025 and a growing mix of interest-bearing loans. A credib...

Trade Idea Long
UNITEDHEALTH GROUP INCORPORATED (Delaware)
Jan 13, 2026

UnitedHealth (UNH) - Bullish Setup: Inflection Confirmation Looks Likely

Near-term swing trade with a position leg for investors who want exposure to an improving cash-flow story and dividend support

UnitedHealth has been repriced lower over the past 18 months, but the company still generates robust operating cash flow, pays a rising dividend and s...

Trade Idea Long
Beam Therapeutics Inc. Common Stock
Jan 13, 2026

Beam Therapeutics: From Platform Beta to Clinical Execution - A Tactical Long Idea

Buy on pullbacks; clinical readouts and orphan designation turn R&D optionality into visible execution

Beam Therapeutics is trading like a research-stage platform while steadily moving into execution mode: orphan designation, non-human primate proof-of-...

Trade Idea Long
TransMedics Group, Inc. Common Stock
Jan 13, 2026

TransMedics (TMDX) - Growth Is Real; Buy the Structural Setup on a Pullback

Strong revenue and margin progression plus healthy operating cash flow make a tactical long here — entry, stops and targets included.

TransMedics reported continued revenue acceleration and meaningful margin improvement in 2025 quarters, supported by positive operating cash flow. Wit...

Trade Idea Long
Akebia Therapeutics, Inc.
Jan 13, 2026

Akebia After the Selloff - Cash-Generating Sales, Cheap On Paper, Binary Catalysts Ahead

Post-drop, Akebia's commercial cash flow and upcoming data present an asymmetric risk/reward for a disciplined long trade

Akebia (AKBA) has seen its share price collapse from multi-dollar levels to the low-$1s despite recent quarters showing positive operating income and ...

Trade Idea Long
Aptiv PLC
Jan 13, 2026

Aptiv (APTV): Buy on Resilient Cash Flow and Non-Auto Diversification

Position trade: play margins recovery and diversified end-markets while respecting earnings volatility

Aptiv's electrical architecture and advanced safety franchises remain structurally exposed to the vehicle electrification and SDV upgrades, but the mo...

Trade Idea Long